Avanos Medical (AVNS) Competitors $12.05 -0.36 (-2.93%) Closing price 03:59 PM EasternExtended Trading$12.05 +0.00 (+0.02%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVNS vs. TMDX, LIVN, ENOV, NVCR, LMAT, CNMD, WRBY, CDRE, KMTS, and TNDMShould you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. Avanos Medical vs. TransMedics Group LivaNova Enovis NovoCure LeMaitre Vascular CONMED Warby Parker Cadre Kestra Medical Technologies Tandem Diabetes Care Avanos Medical (NYSE:AVNS) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, community ranking, analyst recommendations, risk, profitability and earnings. Does the media favor AVNS or TMDX? In the previous week, TransMedics Group had 42 more articles in the media than Avanos Medical. MarketBeat recorded 46 mentions for TransMedics Group and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.13 beat TransMedics Group's score of 0.17 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 11 Very Positive mention(s) 6 Positive mention(s) 25 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral Do analysts rate AVNS or TMDX? TransMedics Group has a consensus price target of $122.70, indicating a potential upside of 43.73%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts plainly believe TransMedics Group is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.82 Which has better earnings and valuation, AVNS or TMDX? TransMedics Group has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvanos Medical$687.80M0.81-$61.80M-$8.53-1.41TransMedics Group$441.54M6.51-$25.03M$1.0184.52 Do insiders & institutionals have more ownership in AVNS or TMDX? 95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 2.6% of Avanos Medical shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is AVNS or TMDX more profitable? TransMedics Group has a net margin of 8.14% compared to Avanos Medical's net margin of 2.30%. TransMedics Group's return on equity of 18.74% beat Avanos Medical's return on equity.Company Net Margins Return on Equity Return on Assets Avanos Medical2.30% 4.70% 3.46% TransMedics Group 8.14%18.74%4.39% Which has more risk and volatility, AVNS or TMDX? Avanos Medical has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Does the MarketBeat Community prefer AVNS or TMDX? TransMedics Group received 25 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 58.95% of users gave TransMedics Group an outperform vote while only 55.77% of users gave Avanos Medical an outperform vote. CompanyUnderperformOutperformAvanos MedicalOutperform Votes8755.77% Underperform Votes6944.23% TransMedics GroupOutperform Votes11258.95% Underperform Votes7841.05% SummaryTransMedics Group beats Avanos Medical on 17 of the 19 factors compared between the two stocks. Remove Ads Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVNS vs. The Competition Export to ExcelMetricAvanos MedicalSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$554.80M$8.61B$5.32B$18.59BDividend YieldN/A1.71%5.11%4.24%P/E Ratio35.4718.5721.7531.22Price / Sales0.8172.20378.5025.74Price / Cash7.6419.6738.1517.54Price / Book0.454.836.444.31Net Income-$61.80M$284.66M$3.20B$1.02B7 Day Performance-2.48%5.46%6.58%6.87%1 Month Performance-16.54%-2.48%-8.54%-6.64%1 Year Performance-36.02%-21.77%10.13%1.48% Avanos Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVNSAvanos Medical3.2236 of 5 stars$12.05-2.9%N/A-32.9%$554.20M$687.80M35.434,040Positive NewsTMDXTransMedics Group2.7651 of 5 stars$69.15+2.2%$122.70+77.4%-5.4%$2.33B$441.54M73.56210LIVNLivaNova3.5551 of 5 stars$35.40-1.5%$61.17+72.8%-33.1%$1.92B$1.25B84.292,900News CoveragePositive NewsGap DownHigh Trading VolumeENOVEnovis2.2051 of 5 stars$32.41-0.4%$58.50+80.5%-44.9%$1.85B$2.11B-14.806,800NVCRNovoCure3.3286 of 5 stars$16.61+0.7%$35.80+115.5%+22.0%$1.83B$605.22M-11.861,320News CoverageLMATLeMaitre Vascular3.2609 of 5 stars$79.39-0.5%$95.25+20.0%+29.6%$1.79B$219.86M43.38490News CoveragePositive NewsHigh Trading VolumeCNMDCONMED4.7494 of 5 stars$55.34-1.6%$77.20+39.5%-31.7%$1.71B$1.31B13.054,100News CoveragePositive NewsWRBYWarby Parker3.3279 of 5 stars$15.43-2.2%$23.43+51.8%+12.9%$1.60B$771.32M-57.153,491Analyst ForecastNews CoveragePositive NewsGap DownCDRECadre3.4082 of 5 stars$28.30+0.5%$37.00+30.7%-7.0%$1.15B$567.56M34.102,240KMTSKestra Medical TechnologiesN/A$22.78-2.1%$27.67+21.5%N/A$1.13B$45.82M0.00300Earnings ReportQuiet Period ExpirationNews CoverageTNDMTandem Diabetes Care4.2061 of 5 stars$16.85-0.2%$45.38+169.3%-49.2%$1.12B$940.20M-8.732,600News CoveragePositive News Remove Ads Related Companies and Tools Related Companies TransMedics Group Competitors LivaNova Competitors Enovis Competitors NovoCure Competitors LeMaitre Vascular Competitors CONMED Competitors Warby Parker Competitors Cadre Competitors Kestra Medical Technologies Competitors Tandem Diabetes Care Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AVNS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVNS Stock Free AVNS Stock Alerts